ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04658	Th1 and Th2 cell differentiation	6/33	96/7206	3.95740993332e-06
ko04060	Cytokine-cytokine receptor interaction	7/33	191/7206	1.96063988761e-05
ko04672	Intestinal immune network for IgA production	4/33	37/7206	2.1644372503e-05
ko04659	Th17 cell differentiation	5/33	106/7206	0.000107135844298
ko05145	Toxoplasmosis	5/33	126/7206	0.000241924761601
ko05140	Leishmaniasis	4/33	75/7206	0.00035241731012
ko04657	IL-17 signaling pathway	4/33	87/7206	0.000620928348238
ko04062	Chemokine signaling pathway	5/33	201/7206	0.00201791129477
ko05310	Asthma	2/33	17/7206	0.00264967778799
ko04514	Cell adhesion molecules (CAMs)	4/33	130/7206	0.00275922595933
ko05332	Graft-versus-host disease	2/33	18/7206	0.00297236913064
ko04640	Hematopoietic cell lineage	3/33	64/7206	0.00301479496081
ko05330	Allograft rejection	2/33	24/7206	0.00527072295434
ko04611	Platelet activation	4/33	163/7206	0.00619218926441
ko04020	Calcium signaling pathway	5/33	265/7206	0.00660581476156
ko05164	Influenza A	4/33	167/7206	0.00674172967364
ko05323	Rheumatoid arthritis	3/33	89/7206	0.00760386191292
ko05320	Autoimmune thyroid disease	2/33	29/7206	0.0076434191952
ko04940	Type I diabetes mellitus	2/33	32/7206	0.00925822253483
ko05152	Tuberculosis	4/33	187/7206	0.00997917711873
ko05150	Staphylococcus aureus infection	2/33	36/7206	0.0116261754288
ko04660	T cell receptor signaling pathway	3/33	124/7206	0.0186343855422
ko05416	Viral myocarditis	2/33	55/7206	0.0259648401589
ko05321	Inflammatory bowel disease (IBD)	2/33	56/7206	0.0268503400567
ko04080	Neuroactive ligand-receptor interaction	5/33	423/7206	0.0415209898683
ko04612	Antigen processing and presentation	2/33	77/7206	0.048078474361
ko04664	Fc epsilon RI signaling pathway	2/33	77/7206	0.048078474361